Vesugen Research Reference

Catalog classification, reference sizes, lab math links, and source-backed data. Educational use only — not medical advice.

Researched for: Vesugen evidence and protocol review

Longevity & Bioregulator Research compound Powder Community-Supported (not scientifically verified)

Also known as: KED, Lys-Glu-Asp

Community-Supported: unlocked based on forum/Reddit discussion, NOT on peer-reviewed or scientific verification. This content is for research and educational reference only. These compounds, protocols, and dosing figures are not verified, may not be FDA-approved, and are not intended for use in humans or animals. Always independently verify before relying on any of this information.

Quick Facts

Reference Sizes
10 mg, 20 mg
Storage
No approved consumer storage standard exists for this presentation; follow the lot-specific COA and validated stability data
Solubility
Lyophilized; reconstitute in sterile bacteriostatic water

Catalog Description

Vesugen (Lys-Glu-Asp) is a tripeptide developed at the St. Petersburg Institute of Bioregulation and Gerontology, studied for vascular endothelial regulation, epigenetic gene-expression normalization, and longevity-related cardiovascular support in aging models. As with other Khavinson-group compounds, evidence is predominantly Russian-language research with limited independent Western replication.

Catalog descriptions reflect research context only. Not a medical claim or treatment recommendation.

Research Profile

Half-Life
Very short (tripeptide, minutes in plasma); tissue-level bioregulatory effects reported to persist longer
Onset
10-day courses, repeated 2-3x per year per originating research protocol
Administration Routes (Research)
SC

Reported Research Effects

Reported Research Side Effects

Data source: Primary literature, regulator records, trial registries, and identity-specific evidence search

Reflects preclinical/research literature context only. Not a medical claim, dosing instruction, or treatment recommendation.

Research Protocols Reported in the Literature

Research Notes

Most claims derive from regional bioregulator literature; the 200-500 mcg SC course was unsupported.

Supplementary research context only. Not medical advice or a treatment recommendation.

Sources

PubMed literature search: Vesugen peptide clinical trial — PubMed (NIH)
https://pubmed.ncbi.nlm.nih.gov/?term=Vesugen%20peptide%20clinical%20trial

Community Discussion Unverified

Best-effort summary of forum/Reddit discussion. This is anecdotal community commentary, not a scientific source, and does not count toward this record's verification status. Do not treat it as established fact or medical guidance.

Community discussion of Vesugen specifically is very limited; most posts are informational overviews rather than reported personal outcomes. A broader assessment of Khavinson-style bioregulators (the peptide family Vesugen belongs to) found independent (non-manufacturer) validation to be limited overall.

Vesugen Peptide: Research Protocols, Mechanisms, and Vascular / Neuroprotection Focus (r/BioLongevityLabs)
https://www.reddit.com/r/BioLongevityLabs/comments/1nrdkz2/vesugen_peptide_research_protocols_mechanisms_and/

Community write-up summarizing claimed research protocols and proposed vascular/neuroprotective mechanisms for Vesugen; informational/summary post rather than a personal-use report.

Khavinson Peptide Bioregulators: Independent Validation Assessment (r/Biohackers)
https://www.reddit.com/r/Biohackers/comments/1rtxdup/khavinson_peptide_bioregulators_independent/

Community post assessing the evidence base behind Khavinson-style short peptide bioregulators (the class Vesugen belongs to), concluding independent validation outside Khavinson-affiliated sources is limited.

Suggest a community source

Found a relevant Reddit or forum thread about this compound? Suggest it below. Every suggestion is reviewed by an editor before it appears -- nothing is published automatically.

Related Research Articles

Published articles on this site that mention Vesugen or one of its catalog aliases.

Related Research Tools

Research Use Only. All content is for educational and research reference only. Not medical advice, a treatment recommendation, or guidance on human use. Compounds are not FDA-approved drugs unless specifically noted.

Scroll to Top